The anticoccidial activity of the ionophore narasin was tested in 3 floor-pen experiments. Narasin was tested at levels of 40, 60, 80, 100, or 120 ppm and compared against feeding ration containing 80, 100, or 121 ppm monensin or no medication. Feeding at all levels of narasin significantly prevented coccidiosis-induced mortality and improved weight gains and feed conversion ratios compared with the same parameters in groups given unmedicated feed. Protection with narasin was equal to or slightly greater than the protection obtained with monensin. The reduction in intestinal lesion scores was greater with narasin medication than with monensin. Analysis of pooled data from these trials indicated that a level between 48 and 96 ppm narasin would provide the optimum, depending on whether maximum weight gain or optimum feed conversion ratio was desired. Testing for coccidial immunity using the immunity challenge technique indicated that, based on the parameters of weight gain and lesion scores, even levels as low as 40 ppm narasin had enough efficacy to significantly reduce the amount of immunity which developed in medicated birds compared with the level of immunity developed in birds receiving unmedicated feed.